Polypeptide Growth Factors in Bone Matrix
- 28 September 2007
- book chapter
- Published by Wiley
- Vol. 136, 207-225
- https://doi.org/10.1002/9780470513637.ch13
Abstract
The presence of many types of polypeptide growth factors in the mineralized extracellular matrix of bone is now well established. These factors are generally referred to as bone-derived growth factors (BDGFs), and are similar, or possibly identical, to the following species; platelet-derived growth factor (PDGF); acidic and basic forms of fibroblast growth factor (aFGF, bFGF); transforming growth factor beta (TGF-beta); and insulin-like growth factor 1 (IGF-1). Several osteoinductive factors, such as bone morphogenetic protein (BMP) and osteogenin, a skeletal growth factor (SGF), and osteoblast-derived BDGFs, have also been identified. Complete description of the biological functions of these BDGFs which are relevant to bone will ultimately require specific bioassays involving specific cell types in vitro, as well as in vivo animal implant models. Studies with primary rat osteoblast-like cells exposed either to mixed BDGFs, pure TGF-beta, or heparin-purified PDGF, aFGF, or bFGF from bovine bone have shown a general dose-dependent mitogenic effect. Phenotypic changes which accompany the BDGF-induced wave of proliferation include: decreased osteocalcin secretion and a reduction in 1,25-(OH)2 vitamin D3-stimulated osteocalcin synthesis; reduced alkaline phosphatase specific activity; decreased cyclic AMP responsiveness to parathyroid hormone (PTH); and increased collagen synthesis. Bone exhibits the most complex spectrum of growth factor activities of any tissue yet described. In bovine bone powder free of blood and cartilage contamination, the volume concentration of mitogens is up to 20 times greater than that in serum. Bone cells and other indigenous cell types must be considered as possible sources of the BDGFs, in addition to sequestration from blood. Mechanisms for the unmasking or release of BDGFs from the mineralized matrix that result in local action on osteoblasts, endothelial cells, and other target cells are undoubtedly important for the development and maintenance of bone tissue.Keywords
This publication has 20 references indexed in Scilit:
- Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular responseBiochemical and Biophysical Research Communications, 1987
- Partial isolation and characterization of a chemotactic factor from adult bovine bone for mesenchymal cellsBone, 1986
- Growth control of cultured rat calvarium cells by platelet-derived growth factorJournal of Oral Pathology & Medicine, 1986
- Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblastsBiochemistry, 1986
- cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell linesNature, 1986
- A significant part of macrophage-derived growth factor consists of at least two forms of PDGFCell, 1985
- Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of boneBiochemical and Biophysical Research Communications, 1983
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983
- Purification of a skeletal growth factor from human boneBiochemistry, 1982
- Chemotaxis of monocytes and neutrophils to platelet-derived growth factor.Journal of Clinical Investigation, 1982